Israelis develop nanotech relief from pain of osteoarthritis

Injections of tiny globules of fat using nanotechnology have been proposed by researchers at the Technion-Israel Institute of Technology and the Hebrew University of Jerusalem to treat the degenerative disease osteoarthritis, the erosion of cartilage in the joints.

The innovative technology will be presented next week at a joint workshop of Israeli and Chinese scientists at the Technion's campus in Haifa. There are about 27 million osteoarthritis patients in the US alone, and it is estimated that 80% of the population will have radiographic evidence of the disease by the age of 65.

The researchers aim to help osteoarthritis patients avoid surgery to replace damaged hip joints and minimize pain by injecting the liposomes into the joints. The liposomes were developed by Hebrew University biochemistry Prof. Yechezkel Barenholz, a world-renowned expert in lipsome fat globules who co-developed Doxil, the world's first approved nanotechnology medicine for slow-release of chemotherapy for breast and ovarian cancer that is in the process of being authorized for other cancers as well.
Lire la suite »
Anti-Boycott Israël blog : ostéoarthrite
Source: article de Judy Siegel-Itzkovich @ TJP (Health and Sci-Tech)